NHMRC Clinical Trials Centre
Cancer trials
  Support for cancer trials
Breast cancer
Gastrointestinal cancer
Germ-cell cancer
Gynaecological cancer
Lung cancer
Brain cancer
Other cancer trials

Trials > Cancer > Other cancer trials{

Other cancer trials

HOSTT: Phase III study to evaluate the impact of maintaining haemoglobin levels above 120 g/L versus over 100 g/L in anaemic patients with carcinoma of the cervix receiving concurrent cisplatin and radiation therapy  

Participants
Women with previously untreated cancer of the cervix receiving concurrent cisplatin chemotherapy and radiation therapy

Treatment
• red cell transfusion

Outcome measures
•
haemoglobin levels
• progression-free survival

Status
Open to recruitment

 

© NHMRC Clinical Trials Centre 2002. Authorised by: Burcu Vachan. Page updated:June 2008